The Vanguard Group 13D and 13G filings for Rigel Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:13 pm Sale | 2023-12-29 | 13G | Rigel Pharmaceuticals, Inc. RIGL | The Vanguard Group | 895,322 5.130% | -313,058 (-25.91%) | Filing |
| 2023-02-09 11:30 am Purchase | 2022-12-30 | 13G | Rigel Pharmaceuticals, Inc. RIGL | The Vanguard Group | 1,208,380 6.990% | 305,568 (+33.85%) | Filing |
| 2022-02-10 08:32 am Sale | 2021-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | The Vanguard Group | 902,811 5.280% | -11,749 (-1.28%) | Filing |